Zobrazeno 1 - 3
of 3
pro vyhledávání: '"The CHICO Study Group"'
Autor:
Danilo Buonsenso, Piero Valentini, Marina Macchi, Francesco Folino, Carola Pensabene, Maria Francesca Patria, Carlo Agostoni, Silvana Castaldi, Maurizio Lecce, Maria Lorella Giannì, Paola Marchisio, Gregorio P. Milani, The CHICO Study Group
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
BackgroundLimited data are available on the attitudes of caregivers toward COVID-19 vaccination in children and adolescents with a history of SARS-CoV-2 infection or Long Covid symptoms. The aim of this study was to investigate the vaccine hesitancy
Externí odkaz:
https://doaj.org/article/1f262e3ef6714dedb585dedd55abee17
Autor:
Giulia Vizzari, Daniela Morniroli, Valentina Tiraferri, Silvana Castaldi, Maria Francesca Patria, Paola Marchisio, Carlo Agostoni, Fabio Mosca, Danilo Buonsenso, Gregorio Paolo Milani, Maria Lorella Giannì, The CHICO Study Group, Francesco Folino, Maria Carola Pensabene, Marina Macchi, Cristina De Rose, Rosa Morello, Carolina Gentili, Margherita Zona, Alessia De Matteis
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
The SARS-CoV-2 (Severe acute respiratory syndrome Coronavirus-2) pandemic has forced the global health system to face new challenges both in the acute management of COVID-19 (Coronavirus Disease 2019) patients and in its consequences. In particular,
Externí odkaz:
https://doaj.org/article/ed2042614c5548ddbc2c54570a4f4bb5
Autor:
Jaime Altcheh, Luis Castro, Juan C Dib, Ulrike Grossmann, Erya Huang, Guillermo Moscatelli, Jimy José Pinto Rocha, Teresa Estela Ramírez, CHICO Study Group
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 1, p e0008912 (2021)
Nifurtimox is a recommended treatment for Chagas disease, but data from treated children are limited. We investigated the efficacy, safety and tolerability of nifurtimox administered as divisible, dispersible 30 mg and 120 mg tablets in children with
Externí odkaz:
https://doaj.org/article/1dcc32d8cefc4129bba991b7e817b145